Techniques in Gastrointestinal Endoscopy
Volume 10, Issue 4 , Pages 184-190 , October 2008

Brachytherapy for Palliaton of Malignant Disease

  • Peter D. Siersema, MD, PhD, FACG

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Peter D. Siersema, MD, PhD, FACG, Department of Gastroenterology & Hepatology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands

References 

  1. Botterweck AA, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:645–654
  2. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053
  3. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29
  4. Sundelof M, Ye W, Dickman PW, et al. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer. 2002;99:751–754
  5. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727–1733
  6. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev CD001556. 2001;
  7. Geh JI. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer. 2002;38:300–313
  8. Stuschke M, Stahl M, Wilke H, et al. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus. Am J Clin Oncol. 2000;23:233–238
  9. Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915–2921
  10. Schraube P, Fritz P, Wannenmacher MF. Combined endoluminal and external irradiation of inoperable oesophageal carcinoma. Radiother Oncol. 1997;44:45–51
  11. Taal BG, Aleman BM, Koning CC, et al. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer. 1996;74:1452–1457
  12. Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001;54:145–153
  13. Christie NA, Buenaventura PO, Fernando HC, et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Ann Thorac Surg. 2001;71:1797–1801
  14. Kozarek RA, Raltz S, Brugge WR, et al. Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fistula. Gastrointest Endosc. 1996;44:562–567
  15. Hishikawa Y, Kurisu K, Taniguchi M, et al. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother Oncol. 1991;21:107–114
  16. Gaspar LE, Nag S, Herskovic A, et al. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer (Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA). Int J Radiat Oncol Biol Phys. 1997;38:127–132
  17. Nickers P, Kunkler I, Scalliet P. Modern brachytherapy: current state and future prospects. Eur J Cancer. 1997;33:1747–1751
  18. Sur RK, Kochhar R, Singh DP. Oral sucralfate in acute radiation oesophagitis. Acta Oncol. 1994;33:61–63
  19. Brewster AE, Davidson SE, Makin WP, et al. Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clin Oncol (R Coll Radiol). 1995;7:102–105
  20. Rowland CG, Pagliero KM. Intracavitary irradiation in palliation of carcinoma of oesophagus and cardia. Lancet. 1985;2:981–983
  21. Jager J, Langendijk H, Pannebakker M, et al. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol. 1995;37:237–240
  22. Sharma V, Mahantshetty U, Dinshaw KA, et al. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2002;52:310–315
  23. Homs MY, Eijkenboom WM, Coen VL, et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol. 2003;66:327–332
  24. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004;364:1497–1504
  25. Kulhavy M, Sur RK, Levin CV, et al. Optimization of single-fraction high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer: a preliminary report. Endocurie Hypertherm Oncol. 1995;11:235–239
  26. Sur RK, Donde B, Levin VC, et al. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;40:447–453
  27. Sur RK, Levin CV, Donde B, et al. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma: an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 2002;53:127–133
  28. Polinder S, Homs MYV, Siersema PD, et al. Cost study of metal stent placement versus single dose brachytherapy in the palliative treatment of oesophageal cancer. Br J Cancer. 2004;90:2067–2072
  29. Homs MYV, Essink-Bot ML, Borsboom GJJM, et al. Quality of life after palliative treatment for esophageal carcinoma: a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer. 2004;40:1862–1871
  30. Homs MYV, Steyerberg EW, Eijkenboom WMH, et al. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer. Brachytherapy. 2006;5:41–48
  31. Steyerberg EW, Homs MYV, Stokvis A, et al. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc. 2005;62:333–340
  32. Dumonceau JM, Cremer M, Lalmand B, et al. Esophageal fistula sealing: choice of stent, practical management, and cost. Gastrointest Endosc. 1999;49:70–78
  33. Morgan RA, Ellul JP, Denton ER, et al. Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses. Radiology. 1997;204:527–532
  34. Siersema PD, Schrauwen SL, van Blankenstein M, et al. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc. 2001;54:579–586
  35. Guo JH, Teng GJ, Zhu GY, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology. 2008;247:574–581

 The author has no direct financial interests that might pose a conflict of interest in connection with the submitted manuscript.

PII: S1096-2883(08)00075-2

doi: 10.1016/j.tgie.2008.07.004

Techniques in Gastrointestinal Endoscopy
Volume 10, Issue 4 , Pages 184-190 , October 2008

Article Tools

* Image Usage & Resolution